Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy

BACKGROUND AND AIM: Anti‐tumor necrosis factor alpha (TNF‐α) therapy is an effective therapy for Crohn's disease (CD). We investigated FoxP3(+) and CD127(−) regulatory T cells (Tregs) before and after administration of anti‐TNF‐α therapy in CD. METHODS: Eight patients with active CD who had rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiba, Toshimi, Endo, Mikiya, Miura, Shoko, Hayashi, Yuko, Asakura, Yoshiko, Oyama, Kotaro, Matsumoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273727/
https://www.ncbi.nlm.nih.gov/pubmed/32514440
http://dx.doi.org/10.1002/jgh3.12259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273727/
https://www.ncbi.nlm.nih.gov/pubmed/32514440
http://dx.doi.org/10.1002/jgh3.12259

Ejemplares similares